Literature DB >> 18852254

MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.

Amrita Dwivedi1, Sadie C Slater, Sarah J George.   

Abstract

AIMS: Vascular smooth muscle cell (VSMC) proliferation contributes to intimal thickening in restenosis and atherosclerosis. Previously, we demonstrated that matrix-degrading metalloproteinase (MMP)-dependent shedding of the extracellular portion of N-cadherin increased VSMC proliferation via elevation of beta-catenin signalling and cyclin D1 expression. In this study, we aimed to determine whether MMP-2, -9, -12, or -14 regulates VSMC proliferation via N-cadherin shedding. METHODS AND
RESULTS: N-cadherin shedding was significantly impaired in proliferating mouse aortic VSMCs deficient in MMP-9 (MMP-9(-/-)) and MMP-12 (MMP-12(-/-)) compared with wild-type controls (1.1 +/- 0.7- and 1.0 +/- 0.1- vs. 2.0 +/- 0.2-fold). Furthermore, proliferating VSMCs subjected to MMP-9 or -12 siRNA knockdown or deficient in MMP-9 or -12 showed significantly increased cellular levels of N-cadherin compared with controls (1.7 +/- 0.2-, 2.7 +/- 0.6-, and 3.5 +/- 1.6-, 1.7 +/- 0.2-fold, respectively). Incubation of VSMCs with active MMP-9 or -12 independently increased N-cadherin cleavage. Additionally, beta-catenin signalling was significantly reduced by 52 +/- 17 and 81 +/- 12% in MMP-9(-/-) and -12(-/-) proliferating VSMCs, respectively, and this was corroborated by siRNA knockdown of MMP-9 and -12. Decreased beta-catenin signalling coincided with significantly reduced proliferation and cyclin D1 protein levels in MMP-9(-/-) and -12(-/-) cells. Little or no additive effect was observed with combined modulation of MMP-9 and -12 in all experiments. In contrast, N-cadherin shedding and VSMC proliferation were not modulated by MMP-2 and -14.
CONCLUSION: In conclusion, we propose that MMP-9 and -12 promote intimal thickening by independent cleavage of N-cadherin, which elevates VSMC proliferation via beta-catenin signalling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852254     DOI: 10.1093/cvr/cvn278

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  49 in total

1.  The NOX-ROS connection: targeting Nox1 control of N-cadherin shedding in vascular smooth muscle cells.

Authors:  Eileen M Redmond; Paul A Cahill
Journal:  Cardiovasc Res       Date:  2012-01-20       Impact factor: 10.787

2.  Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell interactions in vivo.

Authors:  Kyle A DiVito; Valerie A Trabosh; You-Shin Chen; Yu Chen; Chris Albanese; Delphine Javelaud; Alain Mauviel; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Pigment Cell Melanoma Res       Date:  2010-08-25       Impact factor: 4.693

3.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

4.  Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells.

Authors:  Kye-Im Jeon; Hirofumi Jono; Clint L Miller; Yujun Cai; Soyeon Lim; Xuan Liu; Pingjin Gao; Jun-Ichi Abe; Jian-Dong Li; Chen Yan
Journal:  FEBS J       Date:  2010-11-16       Impact factor: 5.542

Review 5.  Casting a net on dendritic spines: the extracellular matrix and its receptors.

Authors:  Lorraine E Dansie; Iryna M Ethell
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

6.  Understanding gene expression in coronary artery disease through global profiling, network analysis and independent validation of key candidate genes.

Authors:  Prathima Arvind; Shanker Jayashree; Srikarthika Jambunathan; Jiny Nair; Vijay V Kakkar
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

7.  Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Ying Ann Chiao; Elizabeth F Lopez; Andrew P Voorhees; Hiroe Toba; Michael E Hall; Hai-Chao Han; Merry L Lindsey; Yu-Fang Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

8.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

9.  Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.

Authors:  Manreet Padwal; Imad Siddique; Lili Wu; Katelynn Tang; Felix Boivin; Limin Liu; Jennifer Robertson; Darren Bridgewater; Judith West-Mays; Azim Gangji; Kenneth Scott Brimble; Peter J Margetts
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

10.  MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis.

Authors:  Helen Williams; Jason L Johnson; Christopher L Jackson; Stephen J White; Sarah J George
Journal:  Cardiovasc Res       Date:  2010-02-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.